• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.25% Nasdaq Up 0.30%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    7.40 Up 0.04(0.54%) 9:51AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.36
    Open:7.41
    Bid:7.40 x 1000
    Ask:7.44 x 200
    1y Target Est:13.57
    Beta:2.23
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:7.39 - 7.49
    52wk Range:3.11 - 9.37
    Volume:125,971
    Avg Vol (3m):5,501,290
    Market Cap:915.59M
    P/E (ttm):N/A
    EPS (ttm):-0.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OREX

    Comparison

    Symbol% ChgMkt Cap
    OREXUp 0.54%915.59M
    ABTDown 0.37%72.64B
    GSKUp 2.07%114.39B
    RHHBYUp 0.39%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16.40
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.54
    Quarterly EPS Est (Mar-15) :-0.14
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-0.69

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products in the United States. The company offers Contrave for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback